| Literature DB >> 30558242 |
Robert Reilly1,2, Susan Spalding3, Brad Walsh4, Jeanne Wainer5, Sue Pickens6, Marcene Royster7, John Villanacci8, Bert B Little9,10,11.
Abstract
Background: We examined the effects of lead on kidney function in occupationally and environmentally exposed adults from a Dallas lead smelter community that was the site of an Environmental Protection Agency (EPA) Superfund clean-up. All subjects were African Americans-a racial group that bears a disproportionate burden of kidney disease.Entities:
Keywords: African-Americans; environmental factors; lead; renal function
Mesh:
Substances:
Year: 2018 PMID: 30558242 PMCID: PMC6313544 DOI: 10.3390/ijerph15122875
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Study group characteristics.
| Interquartile Range | |||||
|---|---|---|---|---|---|
| Total Sample |
| Mean | SD | 25th | 75th |
| Age (years) | 778 | 46.9 | 14.5 | 36 | 57 |
| Duration of residence (years) | 19.4 | 13.4 | 9 | 27 | |
| Blood Lead (µg/dL) | 2.2 | 2.2 | 1 | 3 | |
| Creatinine (mg/dL) | 1.04 | 0.53 | 0.9 | 1.1 | |
| eGFR (mL/min/1.73 m2) | 91.4 | 24.1 | 76.4 | 105.4 | |
| Diabetes ** | 117 | 15.00% | |||
| Hypertension *** | 568 | 73.00% | |||
| Smoke Tobacco | 230 | 29.50% | |||
|
| |||||
| Age (years) | 290 | 43 | 14.1 | 33 | 48.8 |
| Duration of residence (years) | 11.5 | 11.9 | 0 | 24 | |
| Blood Lead (µg/dL) | 2.7 | 2.5 | 1 | 3 | |
| Creatinine (mg/dL) | 1.2 | 0.66 | 1 | 1.2 | |
| eGFR (mL/min/1.73 m2) | 96 | 24.20% | 84.3 | 108.7 | |
| Diabetes ** | 23 | 7.90% | |||
| Hypertension *** | 172 | 59.30% | |||
| Smoke Tobacco | 104 | 36.00% | |||
|
| |||||
| Age (years) | 436 | 47.7 | 14.3 | 25.3 | 54 |
| Duration of residence (years) | 13.1 | 12.9 | 10 | 24 | |
| Blood Lead (µg/dL) | 1.8 | 1.4 | 1 | 2 | |
| Creatinine (mg/dL) | 0.94 | 0.41 | 1 | 1.2 | |
| eGFR (mL/min/1.73 m2) | 89.8 | 23.3 | 76.5 | 102.2 | |
| Diabetes ** | 82 | 18.80% | |||
| Hypertension *** | 356 | 81.70% | |||
| Smoke Tobacco | 104 | 23.80% | |||
|
| |||||
| Age (years) | 52 | 55.8 | 10.5 | 48 | 64 |
| Duration of residence (years) | 14.1 | 12.2 | 7.3 | 30.8 | |
| Blood Lead (µg/dL) | 4.5 | 5 | 2 | 5 | |
| Creatinine (mg/dL) | 1.3 | 0.67 | 1 | 1.4 | |
| eGFR (mL/min/1.73 m2) | 85.2 | 26.5 | 68.5 | 103.2 | |
| Diabetes ** | 12 | 23.10% | |||
| Hypertension *** | 40 | 76.90% | |||
| Smoke Tobacco | 28 | 53.80% | |||
All subjects are African American; ** HbA1c ≥ 6.5; *** 140/90 mmHg or greater, or on anti-hypertensive medications. eGFR: Estimated glomerular filtration rate.
Regressions of estimated glomerular filtration rate (eGFR) on log10 blood lead, duration of residence, diabetes, and hypertension: Effects on Renal Function.
| GFR Units Scaled |
| B | SE |
| eGFR Decrement per 10 μg/dL ↑ Pb |
|---|---|---|---|---|---|
|
| |||||
| Log blood lead | 778 | −22.84 | 3.85 | 0.0001 | −22.8 mL/min/1.73 m2 |
| Duration of residence | −0.11 | 0.07 | 0.11 | ||
| Diabetes | −7.42 | 2.42 | 0.002 | ||
| Hypertension | −8.08 | 1.9 | 0.0001 | ||
| Smoking Tobacco | 7.9 | 0.99 | 0.0001 | ||
| Intercept | 107.67 | 2.29 | 0.0001 | ||
|
| |||||
| Log blood lead | 290 | −21.19 | 7.15 | 0.003 | −21.2 mL/min/1.73 m2 |
| Duration of residence | 0.04 | 0.13 | 0.75 | ||
| Diabetes | −1.36 | 5.47 | 0.8 | ||
| Hypertension | −5.87 | 3.47 | 0.09 | ||
| Smoking Tobacco | 9.95 | 3.51 | 0.005 | ||
| Intercept | 106.39 | 4.47 | 0.0001 | ||
|
| |||||
| Log blood lead | 436 | −25.27 | 5.07 | 0.0001 | −25.3 mL/min/1.73 m2 |
| Duration of residence | −0.10 | 0.08 | 0.22 | ||
| Diabetes | −8.40 | 2.82 | 0.003 | ||
| Hypertension | −9.46 | 2.29 | 0.0001 | ||
| Smoking Tobacco | 4.22 | 2.59 | 0.11 | ||
| Intercept | 107.83 | 2.74 | 0.0001 | ||
|
| |||||
| Log blood lead | 52 | −59.16 | 13.64 | 0.0001 | −59.2 mL/min/1.73 m2 |
| Duration of residence | −0.54 | 0.23 | 0.03 | ||
| Diabetes | −9.09 | 7.98 | 0.26 | ||
| Hypertension | −0.90 | 9.16 | 0.92 | ||
| Smoke Tobacco | 13.11 | 7.18 | 0.08 | ||
| Intercept | 133.98 | 15.14 | 0.0001 |
B—regression slope; SE—standard error.